-
Will The Rally In Tekmira Pharmaceuticals Hold?
Monday, January 12, 2015 - 4:15pm | 366A stock that made headlines on a few different occasions in 2014 is back at it in 2015. Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) is over $20.00 for the first time since late October. In Monday's session, it is trading higher by more than 50 percent. Has This Happened Before?...
-
Glaucus Research Profiles Tekmira Pharmaceuticals; Shares Down 2%
Monday, November 10, 2014 - 2:22pm | 227Shares of Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) were trading lower on Monday after Glaucus Research highlighted a “Strong Sell” recommendation with a $7 to $10 price target. “Tekmira is hugely overvalued and its share price is poised to collapse,” Glaucus...
-
Biotechs That Might Benefit From Ebola Research
Monday, August 11, 2014 - 3:29pm | 389A lot of news has been circulating in regards to stocks that could benefit from the recent Ebola virus outbreak. Although investors might want to proceed with caution when it comes to these news-driven biotech stocks, it never hurts to review the landscape for potential opportunities. Related...
-
4 Ebola Researching Biotech Companies For Your Portfolio
Thursday, August 7, 2014 - 9:15am | 896With the death toll from West Africa’s Ebola outbreak reaching close to 1,000, serious interest is being taken into researching compounds that could both prevent outbreak and help those infected. Until recently, Ebola was a pretty rare disease, Dr. Jim Wilson told Benzinga, and the...